Oncology & Cancer

Unmutated tumor antigens: Exploitable targets for immunotherapy

A team headed by Claude Perreault, Director of IRIC's Immunobiology Research Unit and Professor at the Faculty of Medicine at Université de Montréal, has identified novel tumor antigens that could lead to the development ...

Diseases, Conditions, Syndromes

AI sharpens pathologists' interpretation of tissue samples

Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately. This is shown ...

page 3 from 40